Status:
UNKNOWN
Evaluation of a New Regional Organization to Promote Access to Renal Transplantation
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Renal Failure
Eligibility:
All Genders
18-84 years
Brief Summary
Patients with terminal chronic kidney disease (CRD) need renal function supplementation, namely dialysis or renal transplantation. Transplantation is the most efficient and cost-effective treatment. E...
Eligibility Criteria
Inclusion
- Patient older than 18 years and younger than 85 years.
- Entered in the French Network Epidemiology and Information in Nephrology register
- Renal function supplementation begun in 2013 -- 2014 (period before regional organization implementation) or in 2018 -- 2019 (period after regional organization implementation).
Exclusion
- \- Patient followed in a Center of nephrology-dialysis or of Renal transplantation located outside French Auvergne Rhône Alpes or Center Regions.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT03234075
Start Date
January 1 2018
End Date
January 1 2023
Last Update
January 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Transplantation, Groupement Hospitalier Edouard Herriot, Hospices Civils de Lyon
Lyon, France, 69003